Photo from Emanuele Ammatuna/LinkedIn
Nov 4, 2023, 00:28
Emanuele Ammatuna: Time to reconsider 3+7 for older patients fit for allogenic stem cell transplantation
Emanuele Ammatuna, Hematologist at University Medical Center Groningen, shared on LinkedIn:
“Time to reconsider 3+7 for older patients fit for allogenic stem cell transplantation. The addition of a bcl-2 inhibitor to HMA should be the next investigation in this category of patients.”
Source: Emanuele Ammatuna/LinkedIn
-
Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Apr 1, 2025, 12:16
Apr 1, 2025, 12:13
Apr 1, 2025, 12:07
Apr 1, 2025, 11:53
Apr 1, 2025, 11:51
Apr 1, 2025, 11:42